pI: 7.2644 |
Length (AA): 431 |
MW (Da): 51312 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
79 | 368 | 1e9g (A) | 1 | 284 | 34.00 | 0 | 1 | 1.12376 | -0.21 |
110 | 283 | 4lug (A) | 35 | 180 | 38.00 | 0.00000000089 | 1 | 0.630595 | 0.19 |
189 | 377 | 4uos (A) | 2 | 180 | 17.00 | 0.57 | 0.05 | 0.639668 | -0.53 |
108 | 366 | 5c5v (A) | 147 | 410 | 31.00 | 0.000000029 | 1 | 0.900828 | -0.2 |
130 | 419 | 1e9g (A) | 1 | 284 | 33.00 | 0 | 1 | 1.00615 | -0.04 |
168 | 351 | 3sw5 (A) | 10 | 166 | 35.00 | 0.00095 | 1 | 0.563314 | 0.25 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Sporozoite, Female Gametocyte, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, Ring. | Otto TD Zanghi G |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_127487)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G09650 | soluble inorganic pyrophosphatase 1 |
Babesia bovis | BBOV_III010840 | inorganic pyrophosphatase family protein |
Brugia malayi | Bm1_16955 | inorganic pyrophosphatase |
Candida albicans | CaO19.3590 | inorganic pyrophosphatase |
Candida albicans | CaO19.11072 | inorganic pyrophosphatase |
Caenorhabditis elegans | CELE_C47E12.4 | Protein PYP-1, isoform D |
Cryptosporidium hominis | Chro.40159 | inorganic pyrophosphatase precursor |
Cryptosporidium parvum | cgd4_1400 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0284265 | inorganic pyrophosphatase |
Drosophila melanogaster | Dmel_CG4634 | Nucleosome remodeling factor - 38kD |
Entamoeba histolytica | EHI_124880 | inorganic pyrophosphatase, putative |
Homo sapiens | ENSG00000138777 | pyrophosphatase (inorganic) 2 |
Homo sapiens | ENSG00000180817 | pyrophosphatase (inorganic) 1 |
Leishmania braziliensis | LbrM.19.0110 | acidocalcisomal pyrophosphatase |
Leishmania donovani | LdBPK_110210.1 | acidocalcisomal pyrophosphatase |
Leishmania infantum | LinJ.11.0210 | acidocalcisomal pyrophosphatase |
Leishmania major | LmjF.11.0210 | acidocalcisomal pyrophosphatase |
Leishmania mexicana | LmxM.11.0210 | acidocalcisomal pyrophosphatase |
Loa Loa (eye worm) | LOAG_03390 | inorganic pyrophosphatase |
Mus musculus | ENSMUSG00000028013 | pyrophosphatase (inorganic) 2 |
Mus musculus | ENSMUSG00000020089 | pyrophosphatase (inorganic) 1 |
Neospora caninum | NCLIV_028850 | soluble inorganic pyrophosphatase, putative |
Oryza sativa | 4330852 | Os02g0768600 |
Plasmodium berghei | PBANKA_0414100 | inorganic pyrophosphatase, putative |
Plasmodium falciparum | PF3D7_0316300 | inorganic pyrophosphatase, putative |
Plasmodium knowlesi | PKNH_0825800 | inorganic pyrophosphatase, putative |
Plasmodium vivax | PVX_095420 | inorganic pyrophosphatase, putative |
Plasmodium yoelii | PY03581 | inorganic pyrophosphatase, putative |
Saccharomyces cerevisiae | YBR011C | inorganic diphosphatase IPP1 |
Schmidtea mediterranea | mk4.000077.06 | |
Trypanosoma brucei gambiense | Tbg972.11.8000 | acidocalcisomal pyrophosphatase, putative |
Trypanosoma brucei gambiense | Tbg972.11.8020 | acidocalcisomal pyrophosphatase, putative |
Trypanosoma brucei | Tb927.11.7060 | acidocalcisomal pyrophosphatase |
Trypanosoma brucei | Tb927.11.7080 | acidocalcisomal pyrophosphatase |
Trypanosoma congolense | TcIL3000_0_38820 | acidocalcisomal pyrophosphatase |
Trypanosoma congolense | TcIL3000.11.7660 | acidocalcisomal pyrophosphatase |
Trypanosoma cruzi | TcCLB.511165.40 | acidocalcisomal pyrophosphatase, putative |
Trypanosoma cruzi | TcCLB.503613.60 | acidocalcisomal pyrophosphatase, putative |
Toxoplasma gondii | TGME49_283830 | type I inorganic pyrophosphatase PPase |
Theileria parva | TP02_0061 | inorganic pyrophosphatase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.4930 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.4930 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.4930 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.4930 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.02.4910 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.4910 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.4910 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.4910 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C47E12.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C47E12.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C47E12.4 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C47E12.4 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C47E12.4 | Caenorhabditis elegans | sterile | wormbase |
YBR011C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_283830 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.